Use of Limosilactobacillus reuteri DSM 17938 in paediatric gastrointestinal disorders: an updated review.
- 2022-08-03
- Review
- Beneficial Microbes 13(3)
- V. Dargenio
- F. Cristofori
- C. Dargenio
- P. Giordano
- F. Indrio
- G. Celano
- R. Francavilla
- PubMed: 35212258
- DOI: 10.3920/BM2021.0151
- Low evidence
showing a significant decrease of antibiotic-associated side effects and a tendency to increase the eradication rate
- Effect
- Neutral
- Effect size
- Small
- Significant
- No